WILLIAM A HAGOPIAN, MD
Osteopathic Medicine at Pacific St, Seattle, WA
License number
Washington MD00026590
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
1959 NE Pacific St, Seattle, WA 98195
Phone
(206) 598-4882
(206) 910-1884
(206) 910-1884
Organization information
See more information about WILLIAM A HAGOPIAN at bizstanding.comWilliam Hagopian MD
1959 NE Pacific St, Seattle, WA 98195
Industry:
Internist
Phone:
(206) 598-4882 (Phone)
William Arthur Hagopian
Professional information
William Arthur Hagopian, Seattle WA
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism, Endocrinology and Metabolism
Work:
University Of Washington Medical Ctr
1959 Ne Pacific St, Seattle, WA 98195 Uwmc Roosevelt Diabetes Care Center
4225 Roosevelt Way NE, Seattle, WA 98105
1959 Ne Pacific St, Seattle, WA 98195 Uwmc Roosevelt Diabetes Care Center
4225 Roosevelt Way NE, Seattle, WA 98105
Education:
University of Chicago (1987)
William A Hagopian, Seattle WA
Specialties:
Endocrinologist
Address:
4225 Roosevelt Way Ne, Seattle, WA 98105
University Of Washington Medical Ctr, Seattle, WA 98195
University Of Washington Medical Ctr, Seattle, WA 98195
Education:
University of Chicago, Pritzker School of Medicine - Doctor of Medicine
University of Washington Medical Center - Fellowship - Endocrinology
University of Washington Medical Center - Residency - Internal Medicine
University of Washington Medical Center - Fellowship - Endocrinology
University of Washington Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Endocrinology, Diabetes, and Metabolism (Internal Medicine)
Dr. William A Hagopian, Seattle WA - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism
Address:
Diabetes Care Center
4225 Roosevelt Way NE STE 101, Seattle 98105
(206) 598-4882 (Phone)
4225 Roosevelt Way NE STE 101, Seattle 98105
(206) 598-4882 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 2009, Internal Medicine, 1990
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Diabetes Care Center
4225 Roosevelt Way NE STE 101, Seattle 98105
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
4225 Roosevelt Way NE STE 101, Seattle 98105
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1987
University Of Washington
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1987
University Of Washington
Islet Cell Antigen 1851
US Patent:
6627735, Sep 30, 2003
Filed:
Jun 7, 2001
Appl. No.:
09/876527
Inventors:
Wayne Kindsvogel - Seattle WA
Laura J. Jelinek - Seattle WA
Paul O. Sheppard - Redmond WA
William A. Hagopian - Seattle WA
James M. LaGasse - Seattle WA
Laura J. Jelinek - Seattle WA
Paul O. Sheppard - Redmond WA
William A. Hagopian - Seattle WA
James M. LaGasse - Seattle WA
Assignee:
ZymoGenetics, Inc. - Seattle WA
International Classification:
C07K 100
US Classification:
530350, 4241851
Abstract:
A mammalian islet cell antigen polypeptide involved in the development of insulin-dependent diabetes mellitus (IDDM) is disclosed. This islet cell antigen polypeptide, 1851, was found to contain regions of homology to the protein tyrosine phosphatase family. Methods for diagnosis and treatment, including use in immunoprecipitation assays and the induction of immune tolerance using the recombinant mammalian polypeptides and antibodies specific to mammalian islet cell antigen 1851 polypeptides are presented.
Islet Cell Antigen 1851
US Patent:
6300093, Oct 9, 2001
Filed:
Mar 5, 1997
Appl. No.:
8/811481
Inventors:
Wayne Kindsvogel - Seattle WA
Laura J. Jelinek - Seattle WA
Paul O. Sheppard - Redmond WA
William A. Hagopian - Seattle WA
James M. LaGasse - Seattle WA
Laura J. Jelinek - Seattle WA
Paul O. Sheppard - Redmond WA
William A. Hagopian - Seattle WA
James M. LaGasse - Seattle WA
Assignee:
ZymoGenetics, Inc. - Seattle WA
University of Washington - Seattle WA
University of Washington - Seattle WA
International Classification:
C12P 2106, C12N 120, C07H 2100
US Classification:
435 691
Abstract:
A mammalian islet cell antigen polypeptide involved in the development of insulin-dependent diabetes mellitus (IDDM) is disclosed. This islet cell antigen polypeptide, 1851, was found to contain regions of homology to the protein tyrosine phosphatase family. Methods for diagnosis and treatment, including use in immunoprecipitation assays and the induction of immune tolerance using the recombinant mammalian polypeptides and antibodies specific to mammalian islet cell antigen 1851 polypeptides are presented.
Cloning And Expression Of Human Islet Glutamic Acid Decarboxylase Autoantigen
US Patent:
5792620, Aug 11, 1998
Filed:
Aug 17, 1993
Appl. No.:
8/108145
Inventors:
Ake Lernmark - Seattle WA
Allan E. Karlsen - Valby, DE
Catherine E. Grubin - Seattle WA
William Hagopian - Seattle WA
Patrick J. O'Hara - Seattle WA
Donald C. Foster - Seattle WA
Allan E. Karlsen - Valby, DE
Catherine E. Grubin - Seattle WA
William Hagopian - Seattle WA
Patrick J. O'Hara - Seattle WA
Donald C. Foster - Seattle WA
Assignee:
The Board of Regents of the University of Washington - Seattle WA
ZymoGenetics, Inc. - Seattle WA
ZymoGenetics, Inc. - Seattle WA
International Classification:
G01N 33543
US Classification:
435 795
Abstract:
Human pancreatic islet cell glutamic acid decarboxylase (GAD), an autoantigen involved in the development of insulin-dependent diabetes mellitus (IDDM), has been cloned, sequenced and expressed by recombinant means. Recombinant human islet cell GAD polypeptides and antibodies specific to the GAD polypeptides can be used in methods of diagnosis and treatment, including use in immunoadsorptive therapy and the induction of immune tolerance.
Cloning And Expression Of Human Islet Glutamic Acid Decarboxylase Autoantigen
US Patent:
6025176, Feb 15, 2000
Filed:
May 30, 1995
Appl. No.:
8/453040
Inventors:
Ake Lernmark - Seattle WA
Allan E. Karlsen - Valby, DK
Catherine E. Grubin - Seattle WA
William Hagopian - Seattle WA
Patrick J. O'Hara - Seattle WA
Donald C. Foster - Seattle WA
Allan E. Karlsen - Valby, DK
Catherine E. Grubin - Seattle WA
William Hagopian - Seattle WA
Patrick J. O'Hara - Seattle WA
Donald C. Foster - Seattle WA
Assignee:
The Board of Regents of the University of Washington and ZymoGenetics,
Inc. - Seattle WA
Inc. - Seattle WA
International Classification:
C12N 914, C12P 2106, A61K 3800, A61K 3804
US Classification:
435195
Abstract:
Human pancreatic islet cell glutamic acid decarboxylase (GAD), an autoantigen involved in the development of insulin-dependent diabetes mellitus (IDDM), has been cloned, sequenced and expressed by recombinant means. Recombinant human islet cell GAD polypeptides and antibodies specific to the GAD polypeptides can be used in methods of diagnosis and treatment, including use in immunoadsorptive therapy and the induction of immune tolerance.
Diagnosis Of Insulin-Dependent Diabetes
US Patent:
5547847, Aug 20, 1996
Filed:
Sep 7, 1993
Appl. No.:
8/117907
Inventors:
William Hagopian - Seattle WA
Ake Lernmark - Malmo, SE
Allan E. Karlsen - Aller.o slashed.d, DK
Mona Landin-Olsson - Lund, SE
Ake Lernmark - Malmo, SE
Allan E. Karlsen - Aller.o slashed.d, DK
Mona Landin-Olsson - Lund, SE
Assignee:
University of Washington - Seattle WA
International Classification:
G01N 33573
US Classification:
435 74
Abstract:
Methods for predicting the clinical course of diabetes in patients diagnosed as having NIDDM are provided. Patients having NIDDM are tested for the presence of autoantibodies to human islet cell glutamic acid decarboxylase. Based on the presence or absence of autoantibodies, the patients are classified as to the predicted course of the disease. These methods can be used to predict the development of IDDM and to guide therapeutic intervention.
Islet Cell Antigen 1851
US Patent:
2003016, Sep 4, 2003
Filed:
Apr 16, 2002
Appl. No.:
10/124089
Inventors:
Wayne Kindsvogel - Seattle WA, US
Laura Jelinek - Seattle WA, US
Paul Sheppard - Granite Falls WA, US
William Hagopian - Seattle WA, US
James LaGasse - Seattle WA, US
Laura Jelinek - Seattle WA, US
Paul Sheppard - Granite Falls WA, US
William Hagopian - Seattle WA, US
James LaGasse - Seattle WA, US
Assignee:
ZymoGenetics, Inc.
International Classification:
G01N033/567, C07H021/04, C12P021/02, C12N005/06, C07K014/435, C07K016/40, C12N005/06
US Classification:
435/069100, 435/325000, 435/320100, 435/326000, 435/007210, 530/388260, 530/350000, 536/023500
Abstract:
A mammalian islet cell antigen polypeptide involved in the development of insulin-dependent diabetes mellitus (IDDM) is disclosed. This islet cell antigen polypeptide, 1851, was found to contain regions of homology to the protein tyrosine phosphatase family. Methods for diagnosis and treatment, including use in immunoprecipitation assays and the induction of immune tolerance using the recombinant mammalian polypeptides and antibodies specific to mammalian islet cell antigen 1851 polypeptides are presented.
Methods For Screening For Genetic Predisposition To Type I Diabetes
US Patent:
8268561, Sep 18, 2012
Filed:
Apr 8, 2009
Appl. No.:
12/420722
Inventors:
William Hagopian - Seattle WA, US
Hui Peng - Seattle WA, US
Hui Peng - Seattle WA, US
Assignee:
Pacific Northwest Research Institute - Seattle WA
International Classification:
C12Q 1/68, C12P 19/34
US Classification:
435 611, 435 612
Abstract:
A method of genetically screening large numbers of individuals to identify those individuals requiring follow-up testing for active Type I diabetes (T1D) is provided. The method includes obtaining a nucleic-acid containing biological sample from each individual and testing for the presence of specific combinations of HLA II alleles in the sample.